Tear Fluid Protein Biomarkers

Advances in Clinical Chemistry

Volumn 62, Issue , 2013, Pages 151-196

  You, Jingjing ^a   Willcox, Mark D ^b   Madigan, Michele C ^a,b   Wasinger, Valerie ^b   Schiller, Belinda ^c   Walsh, Bradley J ^c   Graham, Peter H ^d,e   Kearsley, John H ^d,e   Li, Yong ^a,d,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Minomic Pty Ltd   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Biomarkers; Mass spectrometry; Proteomics; Tears

Indexed keywords

BIOLOGICAL MARKER; EYE PROTEIN; TEAR PROTEINS;

ALLERGIC CONJUNCTIVITIS; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; DRY EYE; HUMAN; ISOLATION AND PURIFICATION; LACRIMAL APPARATUS; LACRIMAL FLUID; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; SECRETION (PROCESS); TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CONJUNCTIVITIS, ALLERGIC; DRY EYE SYNDROMES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; HUMANS; LACRIMAL APPARATUS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TEARS;

EID: 84888407118     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800096-0.00004-4     Document Type: Chapter

References (191)

1. Holly F.J., Lemp M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 1977, 22(2):69-87.
2. Dohlman C.H. The function of the corneal epithelium in health and disease. Invest. Ophthalmol. Vis. Sci. 1971, 10(6):383-407.
3. Fatt I., Bieber M.T. The steady-state distribution of oxygen and carbon dioxide in the in vivo cornea: I. The open eye in air and the closed eye. Exp. Eye Res. 1968, 7(1):103-112.
4. Bonanno J.A., Stickel T., Nguyen T., et al. Estimation of human corneal oxygen consumption by noninvasive measurement of tear oxygen tension while wearing hydrogel lenses. Invest. Ophthalmol. Vis. Sci. 2002, 43(2):371-376.
5. Larrea X., Büchler P. A transient diffusion model of the cornea for the assessment of oxygen diffusivity and consumption. Invest. Ophthalmol. Vis. Sci. 2009, 50(3):1076-1080.
6. Bonanno J.A., Clark C., Pruitt J., Alvord L. Tear oxygen under hydrogel and silicone hydrogel contact lenses in humans. Optom. Vis. Sci. 2009, 86(8):E936-E942.
7. O'leary D.J., Wilson G., Bergmanson J. The influence of calcium in the tear-side perfusate on desquamation from the rabbit corneal epithelium. Curr. Eye Res. 1985, 4(6):729-731.
8. Montés-Micó R. Role of the tear film in the optical quality of the human eye. J. Cataract Refract. Surg. 2007, 33(9):1631-1635.
9. Barbero S. Refractive power of a multilayer rotationally symmetric model of the human cornea and tear film. J. Opt. Soc. Am. A 2006, 23(7):1578-1585.
10. Tutt R., Bradley A., Begley C., Thibos L.N. Optical and visual iImpact of tear break-up in human eyes. Invest. Ophthalmol. Vis. Sci. 2000, 41(13):4117-4123.
11. Montés-Micó R., Cáliz A., Alió J.L. Changes in ocular aberrations after instillation of artificial tears in dry-eye patients. J. Cataract Refract. Surg. 2004, 30(8):1649-1652.
12. Situ P., Simpson T.L. Interaction of corneal nociceptive stimulation and lacrimal secretion. Invest. Ophthalmol. Vis. Sci. 2010, 51(11):5640-5645.
13. Hay J.R. Tears-formation and function, wet and dry eyes*. Aust. J. Optom. 1978, 61(11):398-403.
14. Wilson G., O'leary D.J., Holden B.A. Cell content of tears following overnight wear of a contact lens. Curr. Eye Res. 1989, 8(4):329-335.
15. Sack R.A., Tan K.O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 1992, 33(3):626-640.
16. Willcox M.D., Morris C.A., Thakur A., et al. Complement and complement regulatory proteins in human tears. Invest. Ophthalmol. Vis. Sci. 1997, 38(1):1-8.
17. Dartt D.A., Hodges R.R., Zoukhri D. Tears and their secretion. Advances in Organ Biology 2005, vol. 10:21-82. Elsevier, London. J. Fischbarg (Ed.).
18. Dilly P.N. Structure and function of the tear film. Adv. Exp. Med. Biol. 1994, 350:239-247.
19. Chen H.B., Yamabayashi S., Ou B., et al. Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation. Invest. Ophthalmol. Vis. Sci. 1997, 38(2):381-387.
20. Khanal S., Millar T.J. Nanoscale phase dynamics of the normal tear film. Nanomedicine 2010, 6(6):707-713.
21. Ehlers N. The precorneal film. Biomicroscopical, histological and chemical investigations. Acta Ophthalmol. Suppl. 1965, 81(Suppl.):81-134.
22. Mishima S. Some physiological aspects of the precorneal tear film. Arch. Ophthalmol. 1965, 73(2):233-241.
23. King-Smith E., Fink B., Hill R., Koelling K., Tiffany J. The thickness of the tear film. Curr. Eye Res. 2004, 29(4-5):357-368.
24. Danjo Y., Nakamura M., Hamano T. Measurement of the human precorneal tear film with a non-contact optical interferometry film thickness measurement system. Jpn. J. Ophthalmol. 1994, 38:260-266.
25. King-Smith P.E., Fink B.A., Fogt N., et al. The thickness of the human precorneal tear film: evidence from reflection spectra. Invest. Ophthalmol. Vis. Sci. 2000, 41(11):3348-3359.
26. Butovich I.A. The Meibomian puzzle: combining pieces together. Prog. Retin. Eye Res. 2009, 28(6):483-498.
27. Butovich I.A., Arciniega J.C., Lu H., Molai M. Evaluation and quantitation of intact wax esters of human Meibum by gas-liquid chromatography-ion trap mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2012, 53(7):3766-3781.
28. Butovich I., Uchiyama E., Pascuale M., McCulley J. Liquid chromatography-mass spectrometric analysis of lipids present in human Meibomian gland secretions. Lipids 2007, 42(8):765-776.
29. Chen J., Green-Church K.B., Nichols K.K. Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry. Invest. Ophthalmol. Vis. Sci. 2010, 51(12):6220-6231.
30. Nichols K.K., Ham B.M., Nichols J.J., Ziegler C., Green-Church K.B. Identification of fatty acids and fatty acid amides in human meibomian gland secretions. Invest. Ophthalmol. Vis. Sci. 2007, 48(1):34-39.
31. Saville J.T., Zhao Z., Willcox M.D.P., et al. Identification of phospholipids in human meibum by nano-electrospray ionisation tandem mass spectrometry. Exp. Eye Res. 2011, 92(3):238-240.
32. Bron A.J., Tiffany J.M., Gouveia S.M., Yokoi N., Voon L.W. Functional aspects of the tear film lipid layer. Exp. Eye Res. 2004, 78(3):347-360.
33. Saville J.T., Zhao Z., Willcox M.D.P., Blanksby S.J., Mitchell T.W. Detection and quantification of tear phospholipids and cholesterol in contact lens deposits: the effect of contact lens material and lens care solution. Invest. Ophthalmol. Vis. Sci. 2010, 51(6):2843-2851.
34. Van Haeringen N.J. Clinical biochemistry of tears. Surv. Ophthalmol. 1981, 26(2):84-96.
35. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp. Eye Res. 2006, 82(5):885-898.
36. Ohashi Y., Dogru M., Tsubota K. Laboratory findings in tear fluid analysis. Clin. Chim. Acta 2006, 369(1):17-28.
37. Green-Church K.B., Nichols K.K., Kleinholz N.M., Zhang L., Nichols J.J. Investigation of the human tear film proteome using multiple proteomic approaches. Mol. Vis. 2008, 14:456-470.
38. Wei X.E., Markoulli M., Millar T.J., Willcox M.D.P., Zhao Z. Divalent cations in tears, and their influence on tear film stability in humans and rabbits. Invest. Ophthalmol. Vis. Sci. 2012, 53(7):3280-3285.
39. Spurr-Michaud S., Argüeso P., Gipson I. Assay of mucins in human tear fluid. Exp. Eye Res. 2007, 84(5):939-950.
40. Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4(1):45-60.
41. Gipson I.K. Distribution of mucins at the ocular surface. Exp. Eye Res. 2004, 78(3):379-388.
42. McKenzie R.W., Jumblatt J.E., Jumblatt M.M. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva. Invest. Ophthalmol. Vis. Sci. 2000, 41(3):703-708.
43. Nichols B.A., Chiappino M.L., Dawson C.R. Demonstration of the mucous layer of the tear film by electron microscopy. Invest. Ophthalmol. Vis. Sci. 1985, 26(4):464-473.
44. Sharma A. Energetics of corneal epithelial cell-ocular mucus-tear film interactions: some surface-chemical pathways of corneal defense. Biophys. Chem. 1993, 47(1):87-99.
45. Sack R.A., Beaton A., Sathe S., et al. Towards a closed eye model of the pre-ocular tear layer. Prog. Retin. Eye Res. 2000, 19(6):649-668.
46. You J., Hodge C., Wen L., et al. Using soybean trypsin inhibitor as an external loading control for Western blot analysis of tear proteins: application to corneal disease. Exp. Eye Res. 2012, 99:55-62.
47. Small D., Heve J., Tang-Liu D. Comparison of tear sampling techniques for pharmacokinetic analysis: ofloxacin concentrations in rabbit tears after sampling with schirmer tear strips, capillary tubes, or surgical sponges. J. Ocul. Pharmacol. Ther. 2000, 16(5):439-446.
48. Craig J. Structure and function of the preocular tear film. The Tear Film: Structure, Function and Clinical Examination 2002, 18-50. Butterworth-Heinemann, Boston and Oxford. R. Edwards, C. Hutchins (Eds.).
49. Powell D.R., Thangavelu M., Chandler H.L., Nichols K.K., Nichols J.J. Evaluation of extractants and precipitants in tear film proteomic analyses. Optom. Vis. Sci. 2010, 87(11):854-860.
50. Fullard R.J., Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest. Ophthalmol. Vis. Sci. 1990, 31(6):1119-1126.
51. Fullard R.J., Tucker D. Tear protein composition and the effects of stimulus. Adv. Exp. Med. Biol. 1994, 350:309-314.
52. Fullard R.J., Tucker D.L. Changes in human tear protein levels with progressively increasing stimulus. Invest. Ophthalmol. Vis. Sci. 1991, 32(8):2290-2301.
53. Sack R.A., Sathe S., Beaton A. Tear turnover and immune and inflammatory processes in the open-eye and closed-eye environments: relationship to extended wear contact lens use. Eye Contact Lens 2003, 29(1 Suppl.):S192-S194.
54. Gelstein S., Yeshurun Y., Rozenkrantz L., et al. Human tears contain a chemosignal. Science 2011, 331(6014):226-230.
55. Farris R.L. Tear analysis in contact lens wearers. Trans. Am. Ophthalmol. Soc. 1985, 83:501-545.
56. Martin X.D., Brennan M.C. Serotonin in human tears. Eur. J. Ophthalmol. 1994, 4(3):159-165.
57. Markoulli M., Papas E., Petznick A., Holden B. Validation of the flush method as an alternative to basal or reflex tear collection. Curr. Eye Res. 2011, 36(3):198-207.
58. Markoulli M., Papas E., Cole N., Holden B. Differential gel electrophoresis of the tear proteome. Optom. Vis. Sci. 2012, 89(6):E875-E883.
59. González-Pérez J., Villa-Collar C., Sobrino Moreiras T., et al. Tear film inflammatory mediators during continuous wear of contact lenses and corneal refractive therapy. Br. J. Ophthalmol. 2012, 96(8):1092-1098.
60. Poyraz C., Irkec M., Mocan M.C. Elevated tear interleukin-6 and interleukin-8 levels associated with silicone hydrogel and conventional hydrogel contact lens wear. Eye Contact Lens 2012, 38(3):146-149.
61. Tran H.V., Eperon S., Guex-Crosier Y. Persistence of increased Eotaxin-1 (CCL11) level in tears of patients wearing contact lenses: a long-term follow-up study. Klin. Monbl. Augenheilkd. 2011, 228(4):326-329.
62. Balasubramanian S.A., Pye D.C., Willcox M.D.P. Levels of lactoferrin, secretory IgA and serum albumin in the tear film of people with keratoconus. Exp. Eye Res. 2012, 96(1):132-137.
63. Pannebaker C., Chandler H.L., Nichols J.J. Tear proteomics in keratoconus. Mol. Vis. 2010, 16:1949-1957.
64. Wakamatsu T.H., Satake Y., Igarashi A., et al. IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis. Br. J. Ophthalmol. 2012, 96(4):581-586.
65. Sacchetti M., Micera A., Lambiase A., et al. Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. Mol. Vis. 2011, 17:47-52.
66. Atkinson A.J., Colburn W.A., DeGruttola V.G., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework*. Clin. Pharmacol. Ther. 2001, 69(3):89-95.
67. Khleif S.N., Doroshow J.H., Hait W.N. AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin. Cancer Res. 2010, 16(13):3299-3318.
68. Zhou L., Zhao S.Z., Koh S.K., et al. In-depth analysis of the human tear proteome. J. Proteomics 2012, 75(13):3877-3885.
69. Wrotnowski C. The future of plasma proteins-compounds represent both greatest good and worst danger. Genet. Eng. News 1998, 18(11):14.
70. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1(11):845-867.
71. Ginsberg J.M., Chang B.S., Matarese R.A., Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N. Engl. J. Med. 1983, 309(25):1543-1546.
72. Thongboonkerd V. Practical points in urinary proteomics. J. Proteome Res. 2007, 6(10):3881-3890.
73. Grus F.H., Sabuncuo P., Augustin A.J. Analysis of tear protein patterns of dry-eye patients using fluorescent staining dyes and two-dimensional quantification algorithms. Electrophoresis 2001, 22(9):1845-1850.
74. Tiffany J.M. Tears in health and disease. Eye 2003, 17(8):923-926.
75. Herber S., Grus F.H., Sabuncuo P., Augustin A.J. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001, 22(9):1838-1844.
76. Evans V., Vockler C., Friedlander M., Walsh B., Willcox M.D. Lacryglobin in human tears, a potential marker for cancer. Clin. Exp. Ophthalmol. 2001, 29(3):161-163.
77. Böhm D., Keller K., Pieter J., et al. Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach. Oncol. Rep. 2012, 28(2):429-438.
78. Sullivan D., Krenzer K., Sullivan B., et al. Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency?. Invest. Ophthalmol. Vis. Sci. 1999, 40(6):1261-1265.
79. Forster H. ROse bengal test in diagnosis of deficient tear formation. Arch. Ophthalmol. 1951, 45(4):419-424.
80. Lewis J.G. Tear glucose in diabetics. Br. J. Ophthalmol. 1958, 42(12):754-758.
81. Gachon A.M., Verrelle P., Betail G., Dastugue B. Immunological and electrophoretic studies of human tear proteins. Exp. Eye Res. 1979, 29(5):539-553.
82. van Bijsterveld O.P. Diagnostic tests in the sicca syndrome. Arch. Ophthalmol. 1969, 82(1):10-14.
83. van Bijsterveld O. Standardization of the lysozyme test for a commercially available medium: its use for the diagnosis of the sicca syndrome. Arch. Ophthalmol. 1974, 91(6):432-434.
84. Eylan E., Ronen D., Romano A., Smetana O. Lysozyme tear level in patients with herpes simplex virus eye infection. Invest. Ophthalmol. Vis. Sci. 1977, 16(9):850-853.
85. Sen D.K., Sarin G.S. Immunoassay of tear lysozyme in conjunctival diseases. Br. J. Ophthalmol. 1982, 66(11):732-735.
86. Gupta A.K., Sarin G.S., Lamba P.A., D'Souza P. Immunoassay of tear lysozyme in acute adenovirus conjunctivitis. Br. J. Ophthalmol. 1986, 70(6):439-441.
87. Watson R.R., Reyes M.A., McMurray D.N. Influence of malnutrition on the concentration of IgA, lysozyme, amylase, and aminopeptidase in children's tears. Proc. Soc. Exp. Biol. Med. 1978, 157(2):215-219.
88. Zavaro A., Samra Z., Baryishak R., Sompolinsky D. Proteins in tears from healthy and diseased eyes. Doc. Ophthalmol. 1980, 50(1):185-199.
89. Ballow M., Donshik P.C., Rapacz P., Samartino L. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest. Ophthalmol. Vis. Sci. 1987, 28(3):543-545.
90. Janssen P., Bijsterveld O. A simple test for lacrimal gland function: a tear lactoferrin assay by radial immunodiffusion. Graefes Arch. Clin. Exp. Ophthalmol. 1983, 220(4):171-174.
91. Li K., Liu X., Chen Z., Huang Q., Wu K. Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis. Mol. Vis. 2010, 16:2084-2091.
92. Hida R.Y., Ohashi Y., Takano Y., et al. Elevated levels of human α-defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification. Curr. Eye Res. 2005, 30(9):737-744.
93. Koo B.S., Lee D.Y., Ha H.S., Kim J.C., Kim C.W. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J. Proteome Res. 2005, 4(3):719-724.
94. Acera A., Suárez T., Rodríguez-Agirretxe I., Vecino E., Durán J.A. Changes in tear protein profile in patients with conjunctivochalasis. Cornea 2011, 30(1):42-49.
95. Nichols J.J., Green-Church K.B. Mass spectrometry-based proteomic analyses in contact lens-related dry eye. Cornea 2009, 28(10):1109-1117.
96. Zhou L., Beuerman R.W., Chan C.M., et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J. Proteome Res. 2009, 8(11):4889-4905.
97. Srinivasan S., Thangavelu M., Zhang L., Green K.B., Nichols K.K. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest. Ophthalmol. Vis. Sci. 2012, 53(8):5052-5059.
98. Grus F.H., Podust V.N., Bruns K., et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest. Ophthalmol. Vis. Sci. 2005, 46(3):863-876.
99. Saijyothi A.V., Angayarkanni N., Syama C., et al. Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. Electrophoresis 2010, 31(20):3420-3427.
100. Tomosugi N., Kitagawa K., Takahashi N., Sugai S., Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjögren's syndrome. J. Proteome Res. 2005, 4(3):820-825.
101. Acera A., Vecino E., Rodriguez-Agirretxe I., et al. Changes in tear protein profile in keratoconus disease. Eye 2011, 25(9):1225-1233.
102. Ananthi S., Chitra T., Bini R., et al. Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol. Vis. 2008, 14:500-507.
103. Zhou L., Beuerman R.W., Ang L.P.K., et al. Elevation of human α-defensins and S100 calcium-binding proteins A8 and A9 in tear fluid of patients with pterygium. Invest. Ophthalmol. Vis. Sci. 2009, 50(5):2077-2086.
104. Matheis N., Okrojek R., Grus F.H., Kahaly G.J. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid 2012, 22(10):1039-1045.
105. Wong T.T., Zhou L., Li J., et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest. Ophthalmol. Vis. Sci. 2011, 52(10):7385-7391.
106. Kramann C., Boehm N., Lorenz K., et al. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch. Clin. Exp. Ophthalmol. 2011, 249(2):233-243.
107. Calais G., Forzy G., Crinquette C., et al. Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion. Mult. Scler. 2010, 16(1):87-92.
108. Lebrecht A., Boehm D., Schmidt M., et al. Diagnosis of breast cancer by tear proteomic pattern. Cancer Genomics Proteomics 2009, 6(3):177-182.
109. Kim H.-J., Kim P.-K., Yoo H.-S., Kim C.-W. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin. Biochem. 2012, 45(1-2):60-67.
110. Lemp M.A., Baudouin C., Baum J., et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007). Ocul. Surf. 2007, 5(2):75-92.
111. Tong L., Zhou L., Beuerman R.W., Zhao S.Z., Li X.R. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br. J. Ophthalmol. 2011, 95(6):848-852.
112. Enriquez-de-Salamanca A., Castellanos E., Stern M.E., et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol. Vis. 2010, 16:862-873.
113. Massingale M.L., Li X., Vallabhajosyula M., et al. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009, 28(9):1023-1027.
114. Lam H., Bleiden L., de Paiva C.S., et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J. Ophthalmol. 2009, 147(2):198-205. e191.
115. Boehm N., Riechardt A.I., Wiegand M., Pfeiffer N., Grus F.H. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2011, 52(10):7725-7730.
116. Jun A.S., Cope L., Speck C., et al. Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS One 2011, 6(1):e16437.
117. Lema I., Sobrino T., Durán J.A., Brea D., Díez-Feijoo E. Subclinical keratoconus and inflammatory molecules from tears. Br. J. Ophthalmol. 2009, 93(6):820-824.
118. Lema I., Durán J.A. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005, 112(4):654-659.
119. Smith V.A., Rishmawi H., Hussein H., Easty D.L. Tear film MMP accumulation and corneal disease. Br. J. Ophthalmol. 2001, 85(2):147-153.
120. Lema I., Brea D., Rodríguez-González R., Díez-Feijoo E., Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol. Vis. 2010, 16:2055-2061.
121. Lema I., Duran J.A., Ruiz C., et al. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects. Cornea 2008, 27(7):758-763.
122. Leonardi A., Sathe S., Bortolotti M., Beaton A., Sack R. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy 2009, 64(5):710-717.
123. Csosz É., Boross P., Csutak A., et al. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. J. Proteomics 2012, 75(7):2196-2204.
124. Liu J., Shi B., He S., et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol. Vis. 2010, 16:2931-2938.
125. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59(4):225-249.
126. Molloy M.P., Bolis S., Herbert B.R., et al. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis 1997, 18(15):2811-2815.
127. Ouellette R.J., Richard D., Maicas E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am. J. Clin. Pathol. 2004, 121(5):637-643.
128. de Freitas Campos C., Cole N., Dyk D.V., et al. Proteomic analysis of dog tears for potential cancer markers. Res. Vet. Sci. 2008, 85(2):349-352.
129. Wolff S., Otto A., Albrecht D., et al. Gel-free and gel-based proteomics in Bacillus subtilis: a comparative study. Mol Cell Proteomics 2006, 5(7):1183-1192.
130. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422(6928):198-207.
131. Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246(4926):64-71.
132. Karas M., Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60(20):2299-2301.
133. Hutchens T., Yip T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom. 1993, 7:576-580.
134. Issaq H.J., Veenstra T.D., Conrads T.P., Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002, 292(3):587-592.
135. Mann M., Jensen O.N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 2003, 21(3):255-261.
136. Krueger K.E., Srivastava S. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol. Cell. Proteomics 2006, 5(10):1799-1810.
137. Zhao Z., Liu J., Wasinger V.C., et al. Tear lipocalin is the predominant phosphoprotein in human tear fluid. Exp. Eye Res. 2010, 90(2):344-349.
138. You J., Fitzgerald A., Cozzi P.J., et al. Post-translation modification of proteins in tears. Electrophoresis 2010, 31(11):1853-1861.
139. Zhao Z., Liu J., Shi B., et al. Advanced glycation end product (AGE) modified proteins in tears of diabetic patients. Mol. Vis. 2010, 16:1576-1584.
140. Choe L.H., Lee K.H. Quantitative and qualitative measure of intralaboratory two-dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis. Electrophoresis 2003, 24(19-20):3500-3507.
141. Karp N.A., Feret R., Rubtsov D.V., Lilley K.S. Comparison of DIGE and post-stained gel electrophoresis with both traditional and SameSpots analysis for quantitative proteomics. Proteomics 2008, 8(5):948-960.
142. Li N., Wang N., Zheng J., et al. Characterization of human tear proteome using multiple proteomic analysis techniques. J. Proteome Res. 2005, 4(6):2052-2061.
143. Marshall F.F. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. J. Urol. 2005, 173(6):1919-1920.
144. Moshkovskii S.A., Serebryakova M.V., Kuteykin-Teplyakov K.B., et al. Ovarian cancer marker of 11.7kDa detected by proteomics is a serum amyloid A1. Proteomics 2005, 5(14):3790-3797.
145. Matharoo-Ball B., Ball G., Rees R. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches-a prostate cancer perspective. Vaccine 2007, 25:B110-B121.
146. Hodgetts A., Levin M., Kroll J.S., Langford P.R. Biomarker discovery in infectious diseases using SELDI. Fut. Microbiol. 2007, 2(1):35-49.
147. Constantinescu R., Andreasson U., Li S., et al. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat. Disord. 2010, 16(8):545-549.
148. de Seny D., Fillet M., Ribbens C., et al. Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin. Chem. 2008, 54(6):1066-1075.
149. Zhou L., Huang L.Q., Beuerman R.W., et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J. Proteome Res. 2004, 3(3):410-416.
150. Tomosugi N., Kitagawa K., Takahashi N., Sugai S., Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjogren's syndrome.[see comment]. J. Proteome Res. 2005, 4(3):820-825.
151. Petricoin E.F., Liotta L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 2004, 15(1):24-30.
152. Baggerly K.A., Morris J.S., Coombes K.R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004, 20(5):777-785.
153. De Bock M., de Seny D., Meuwis M.A., et al. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J. Biomed. Biotechnol. 2010, 2010:906082. 10.1155/2010/906082.
154. Gygi S.P., Rist B., Gerber S.A., et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17(10):994-999.
155. Ong S.E., Blagoev B., Kratchmarova I., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1(5):376-386.
156. Ross P.L., Huang Y.N., Marchese J.N., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3(12):1154-1169.
157. Wang G., Wu W.W., Zeng W., Chou C.L., Shen R.F. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J. Proteome Res. 2006, 5(5):1214-1223.
158. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19(3):242-247.
159. Lange V., Picotti P., Domon B., Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol. 2008, 4:222. 10.1038/msb.2008.61.
160. Phanstiel D., Unwin R., McAlister G.C., Coon J.J. Peptide quantification using 8-Plex isobaric tags and electron transfer dissociation tandem mass spectrometry. Anal. Chem. 2009, 81(4):1693-1698.
161. Zieske L.R. A perspective on the use of iTRAQ (TM) reagent technology for protein complex and profiling studies. J. Exp. Bot. 2006, 57(7):1501-1508.
162. Boylan K.L.M., Andersen J.D., Anderson L.B., Higgins L., Skubitz A.P.N. Quantitative proteomic analysis by iTRAQ (R) for the identification of candidate biomarkers in ovarian cancer serum. Proteome Sci. 2010, 8:31. 10.1186/1477-5956-1188-1131.
163. Song X.M., Bandow J., Sherman J., et al. iTRAQ experimental design for plasma biomarker discovery. J. Proteome Res. 2008, 7(7):2952-2958.
164. Akkina S.K., Zhang Y., Nelsestuen G.L., Oetting W.S., Ibrahim H.N. Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition?. J. Proteome Res. 2009, 8(1):94-103.
165. Streckfus C.F., Mayorga-Wark O., Arreola D., et al. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest. 2008, 26(2):159-167.
166. Abdi F., Quinn J.F., Jankovic J., et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 2006, 9(3):293-348.
167. DeSouza L., Diehl G., Rodrigues M.J., et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005, 4(2):377-386.
168. Len A.C.L., Powner M.B., Zhu L., et al. Pilot application of iTRAQ to the retinal disease Macular Telangiectasia. J. Proteome Res. 2012, 11(2):537-553.
169. Keshamouni V.G., Michailidis G., Grasso C.S., et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 2006, 5(5):1143-1154.
170. Chen Y., Choong L.Y., Lin Q., et al. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell. Proteomics 2007, 6(12):2072-2087.
171. Rehman I., Evans C.A., Glen A., et al. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer. PLoS One 2012, 7(2):e30885.
172. Wu W.W., Wang G., Baek S.J., Shen R.-F. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D Gel- or LC-MALDI TOF/TOF. J. Proteome Res. 2006, 5(3):651-658.
173. McKay M.J., Sherman J., Laver M.T., et al. The development of multiple reaction monitoring assays for liver-derived plasma proteins. Proteomics Clin. Appl. 2007, 1(12):1570-1581.
174. Kondrat R.W., McClusky G.A., Cooks R.G. Multiple reaction monitoring in mass spectrometry/mass spectrometry for direct analysis of complex mixtures. Anal. Chem. 1978, 50(14):2017-2021.
175. Hiemstra M., de Kok A. Comprehensive multi-residue method for the target analysis of pesticides in crops using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1154(1-2):3-25.
176. Gergov M., Ojanperä I., Vuori E. Simultaneous screening for 238 drugs in blood by liquid chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 795(1):41-53.
177. Wu S.-L., Amato H., Biringer R., et al. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. J. Proteome Res. 2002, 1(5):459-465.
178. Anderson L., Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5(4):573-588.
179. Ackermann B.L., Berna M.J. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers. Expert Rev. Proteomics 2007, 4:175-186.
180. Kuzyk M.A., Smith D., Yang J.C., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 2009, 8(8):1860-1877.
181. Unwin R.D., Griffiths J.R., Leverentz M.K., et al. Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity. Mol. Cell. Proteomics 2005, 4(8):1134-1144.
182. Griffiths J.R., Unwin R.D., Evans C.A., et al. The application of a hypothesis-driven strategy to the sensitive detection and location of acetylated lysine residues. J. Am. Soc. Mass Spectrom. 2007, 18(8):1423-1428.
183. Mayya V., Rezual K., Wu L., Fong M.B., Han D.K. Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin-dependent kinases. Mol. Cell. Proteomics 2006, 5(6):1146-1157.
184. Hülsmeier A.J., Paesold-Burda P., Hennet T. N-Glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry. Mol. Cell. Proteomics 2007, 6(12):2132-2138.
185. Bhatta R., Rathi C., Chandasana H., et al. LC-MS method for determination of amphotericin B in rabbit tears and its application to ocular pharmacokinetic study. Chromatographia 2011, 73(5):487-493.
186. Bhatta R.S., Chandasana H., Rathi C., et al. Bioanalytical method development and validation of natamycin in rabbit tears and its application to ocular pharmacokinetic studies. J. Pharm. Biomed. Anal. 2011, 54(5):1096-1100.
187. Arnold D.R., Granvil C.P., Ward K.W., Proksch J.W. Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 867(1):105-110.
188. Keshishian H., Addona T., Burgess M., Kuhn E., Carr S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6(12):2212-2229.
189. Fortin T., Salvador A., Charrier J.P., et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell. Proteomics 2009, 8(5):1006-1015.
190. Addona T.A., Abbatiello S.E., Schilling B., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27(7):633-641.
191. Rodriguez H., Težak Ž., Mesri M., et al. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin. Chem. 2010, 56(2):237-243.